Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies 
Summary
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The stock is in a well-established, long-term rising trend above the technical support level at 43.16 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Technically, the stock approaches a strong medium-term resistance at USD 48.89.
  • The company's enterprise value to sales, at 3.78 times its current sales, is high.
  • With an expected P/E ratio at 31.69 and 24.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • Analysts covering the stock have recently lowered their earnings forecast.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Subsector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES26.45%84 629
JOHNSON & JOHNSON16.50%361 566
ROCHE HOLDING LTD.8.81%224 305
NOVARTIS7.69%214 091
PFIZER4.31%199 854
MERCK AND COMPANY11.19%176 500
SANOFI12.56%121 796
BAYER22.87%112 101
GLAXOSMITHKLINE7.75%105 158
BRISTOL-MYERS SQUIBB COMPAN..-4.06%91 696
ELI LILLY AND COMPANY12.36%91 303
Autres valeurs du secteur
Company
Engages in the discovery, development, manufacture and sale of health care productsAbbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.It operates through the following segments: Established Pharmaceutical Products,... 
Sector
Pharmaceuticals
Calendar
07/12Ex-dividend day
More about the company
Advertisement
Financials ($)
Sales 2017 26 375 M
EBIT 2017 5 725 M
Net income 2017 2 939 M
Debt 2017 15 411 M
Yield 2017 2,23%
P/E ratio 2017 31,69
P/E ratio 2018 24,86
EV / Sales 2017 3,78x
EV / Sales 2018 3,52x
Capitalization 84 282 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period : Day
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Duration : Period : Week
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
More Ratings